Learn how PharPoint Research’s partnership with Medrio EDC is saving our clients time, money, and stress by guaranteeing fast timelines and greater market share.
In our last article with Medrio, we discussed how being first to the pharmaceutical market is essential, as first-movers usually acquire significantly greater market share. That’s why it’s important to work with a contract research organization (CRO) that guarantees fast timelines and simultaneously mitigates the risk of errors. When deadlines are met and things proceed quickly and accurately, there’s a clear competitive advantage (something that can be difficult to obtain in this industry). For these reasons, you should choose a CRO that seamlessly integrates a clinical trial software, such as Medrio, to meet deadlines quickly while also fitting your budget. For proof, look no further than the PharPoint Research and Medrio team.[bctt tweet=” First-movers to any market acquire significantly greater market share.”]
At PharPoint Research, we’re focused on getting clients to market efficiently by providing high-quality clinical trial management services. Since 2010, PharPoint Research has been using Medrio as our preferred system for Phase I and II electronic data capture (EDC) because of Medrio’s smooth clinical site integration, affordable price, and fast timelines. These qualities, combined with it’s user-friendly and intuitive interface, make Medrio’s EDC one of the best tools in our shed.
PharPoint’s clinical staff agrees that Medrio is user friendly. Our director of clinical operations delved into more detail:
“Medrio’s design facilitates easy adoption by sites who are new to EDC studies or are migrating from another system. Navigation is intuitive and the different data views help sites understand how data is being processed. Medrio’s home page status displays allow sites to view outstanding queries or easily pinpoint which forms are ready for the Private Investigator’s signature.”
Survey Says: PharPoint and Medrio Work Great Together
Recently, PharPoint and Medrio sent a survey to clinical sites and data managers that examined how PharPoint’s experience, combined with Medrio’s user friendly software, is leading to efficient timelines and happy repeat customers. Most of those surveyed agreed that Medrio is intuitive and has fast startup times.
Those surveyed came from a wide variety of ages between 20 and 65, most of whom have been using Medrio for under one year. When asked to describe the best aspects of Medrio, survey participants most often replied that it is easy to use, easy to learn, and user friendly.
The data demonstrates how successful the partnership between PharPoint Research and Medrio has been for Phase I and II studies. By being an accredited Medrio partner, PharPoint is able to build databases in house, which contributes to our fast timelines by cutting down on study database startup times. There is no clunky software, and there is no need to hire a programmer for the software setup. This, along with our clinical experience and flexibility as a CRO, leads to faster timelines and repeat business.
About PharPoint Research
Headquartered in North Carolina’s Research Triangle Park (RTP), PharPoint Research is an award-winning, full service CRO devoted to the administration and implementation of Phase I through IV clinical studies. Specializing in project management, clinical monitoring, data management and biostatistics, PharPoint Research understands the importance of responsiveness and timely deliverables with exceptional quality. PharPoint has a wide breadth of experience with Phase I Clinical Trials in therapeutic areas such as oncology, immunology, and hearing loss.
Founded in 2005, Medrio offers an integrated eClinical software platform with a fully hosted Electronic Data Capture (EDC) system. Their revolutionary SaaS technology drastically reduces study timelines and costs by giving study managers more control over their studies. By simplifying and streamlining the data collection process – without the need for any custom development – Medrio allows researchers to build their studies in days instead of months without any programming knowledge. Plus, Medrio costs up to 75% less than traditional EDC solutions. Their diverse set of customers includes CROs and sponsors conducting studies across all study phases and therapeutic areas, and ranges from newly formed startups to the top 5 biopharmaceutical companies.